LIPAC's drug delivery system is highly versatile, has potential utility for a wide variety of indications, and is particularly well-suited for treating relatively localized diseases where local administration of the therapeutic is possible but is currently ineffective or unsafe. We welcome opportunities to collaborate with biopharmaceutical companies that wish to take advantage of our proliposomal drug delivery system.